Cell MedX Corp. (CMXC) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
820 - 1130 PENDER STREET, WEST VANCOUVER, BC V6E 4A4 |
| State of Incorp. | NV |
| Fiscal Year End | May 31 |
| Industry (SIC) | 59 - Miscellaneous Retail (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 2/29/2024 MRQ | 11/30/2023 MRQ | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 23 | 98 | 24 | 21 | 45 | 57 | |||
| Cash and cash equivalents | 23 | 98 | 24 | 21 | 45 | 57 | |||
| Inventory, net of allowances, customer advances and progress billings | 52 | 73 | |||||||
| Inventory | 52 | 73 | |||||||
| Other current assets | 0 | 5 | 17 | 30 | 60 | 59 | |||
| Total current assets: | 23 | 103 | 41 | 51 | 157 | 189 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1 | 2 | 1 | ||||||
| Total noncurrent assets: | 1 | 2 | 1 | ||||||
| TOTAL ASSETS: | 23 | 103 | 41 | 52 | 159 | 191 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 657 | 445 | 498 | 467 | 943 | 781 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 26 | 21 | ||||
| Accounts payable | 648 | 408 | 442 | 432 | 909 | 734 | |||
| Accrued liabilities | 8 | 37 | 29 | 35 | 35 | 26 | |||
| Debt | 585 | ||||||||
| Due to related parties | ✕ | ✕ | 818 | 234 | 384 | ||||
| Total current liabilities: | 657 | 445 | 498 | 1,285 | 1,177 | 1,749 | |||
| Noncurrent Liabilities | |||||||||
| Other undisclosed liabilities | 1,892 | 2,044 | 1,553 | 344 | 502 | 214 | |||
| Total liabilities: | 2,548 | 2,489 | 2,050 | 1,628 | 1,680 | 1,963 | |||
| Equity | |||||||||
| Equity, attributable to parent | (2,892) | (2,752) | (2,376) | (1,943) | (1,887) | (1,787) | |||
| Common stock | 63 | 63 | 63 | 62 | 56 | 44 | |||
| Common stock, value, subscriptions | 80 | ||||||||
| Additional paid in capital | 7,273 | 7,273 | 7,273 | 7,076 | 5,988 | 5,110 | |||
| Accumulated other comprehensive income (loss) | 63 | 65 | (53) | (121) | 39 | 16 | |||
| Accumulated deficit | (10,290) | (10,153) | (9,658) | (8,960) | (8,050) | (6,957) | |||
| Other undisclosed equity | 366 | 366 | 366 | 366 | 366 | 14 | |||
| Total equity: | (2,525) | (2,385) | (2,009) | (1,576) | (1,520) | (1,773) | |||
| TOTAL LIABILITIES AND EQUITY: | 23 | 103 | 41 | 52 | 159 | 191 | |||
Income Statement (P&L) ($ in thousands)
| 2/29/2024 TTM | 11/30/2023 TTM | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 96 | |||||||
| Cost of revenue (Cost of Goods and Services Sold) | (2) | (3) | (10) | |||||
| Other undisclosed gross profit | 0 | 0 | 6 | 7 | ||||
| Gross profit: | 0 | 0 | 4 | 4 | 86 | |||
| Operating expenses | (264) | (448) | (676) | (729) | (1,124) | 670 | ||
| Operating income (loss): | (264) | (448) | (672) | (725) | (1,038) | 670 | ||
| Nonoperating income (expense) | 9 | 119 | 67 | (159) | (79) | 13 | ||
| Gain (loss), foreign currency transaction, before tax | 9 | 119 | 67 | (159) | 23 | 13 | ||
| Other nonoperating expense | (102) | |||||||
| Interest and debt expense | (71) | (47) | (26) | (186) | 48 | (219) | ||
| Income (loss) from continuing operations before income taxes: | (326) | (376) | (630) | (1,070) | (1,070) | 464 | ||
| Income tax benefit | 146 | 191 | 229 | 190 | ||||
| Income (loss) from continuing operations: | (326) | (376) | (484) | (879) | (840) | 655 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (879) | (840) | 655 | |
| Other undisclosed net income (loss) | (9) | (119) | (214) | (32) | (252) | (1,561) | ||
| Net loss available to common stockholders, diluted: | (335) | (495) | (697) | (911) | (1,093) | (906) | ||
Comprehensive Income ($ in thousands)
| 2/29/2024 TTM | 11/30/2023 TTM | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (335) | (495) | (697) | (911) | (1,093) | (906) | ||
| Comprehensive loss: | (335) | (495) | (697) | (911) | (1,093) | (906) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 9 | 119 | 67 | (159) | 23 | 13 | ||
| Comprehensive loss, net of tax, attributable to parent: | (326) | (376) | (630) | (1,070) | (1,070) | (893) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.